Pasar al contenido principal

Diet, microbiome and intestinal inflammation in infants

FJC2021-047052-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Formación
Convocatoria Juan de la Cierva Formación
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity

  • Gutiérrez-Díaz, Isabel
  • Sanz-Martinez, Miriam
  • Castro, Ana M.
  • Velasco Rodríguez-Belvis, Marta
  • Carreira, Nathalie
  • Jiménez, Santiago
  • Mangas, Carmen
  • Queralt, Macarena
  • Herrador, Marta
  • Martín-Masot, Rafael
  • Ferrer González, Pablo
  • Navas-López, Víctor M.
  • Espín, Beatriz
  • Leis Trabazo, Rosaura
  • Díaz, Juan J.
  • Delgado, Susana
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly worldwide, seriously endangering human health. Although SARS-CoV-2 had a lower impact on paediatric population, children with COVID-19 have been reported as suffering from gastrointestinal (GI) symptoms at a higher rate than adults. The aim of this work was to evaluate faeces as a source of potential biomarkers of severity in the paediatric population, with an emphasis on intestinal microbiota and faecal immune mediators, trying to identify possible dysbiosis and immune intestinal dysfunction associated with the risk of hospitalization. This study involved 19 patients with COVID-19 under 24 months of age hospitalized during the pandemic at 6 different hospitals in Spain, and it included a comparable age-matched healthy control group (n = 18). Patients and controls were stratified according to their age in two groups: newborns or young infants (from 0 to 3 months old) and toddlers (infants from 6 to 24 months old). To characterize microbial intestinal communities, sequencing with Illumina technology of total 16S rDNA amplicons and internal transcribed spacer (ITS) amplicons of bifidobacteria were used. Faecal calprotectin (FC) and a range of human cytokines, chemokines, and growth factors were measured in faecal samples using ELISA and a multiplex system. Significant reduction in the abundance of sequences belonging to the phylum Actinobacteria was found in those infants with COVID-19, as well as in the Bifidobacteriaceae family. A different pattern of bifidobacteria was observed in patients, mainly represented by lower percentages of Bifidobacterium breve, as compared with controls. In the group of hospitalized young infants, FC was almost absent compared to age-matched healthy controls. A lower prevalence in faecal excretion of immune factors in these infected patients was also observed., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This word was funded in part by a CSIC (Consejo Superior de Investigaciones Científicas) internal project PIE reference 202070E237. The research was also funded by the European Commission-Next Generation EU (REGULATION EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global). I. G-D. has a grant FJC2021-047052-I financed by MCIN/AEI/10.13039/501100011033 and by European Union “NextGenerationEU/PRTR.” Grant AYUDA-20201-50910 from the Government of Asturias Principality (FICYT, supported by FEDER) is also received., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Afectación de la microbiota humana por infección por SARS-CoV-2 durante la pandemia en diferentes grupos de edad en España. Experiencia de la Plataforma PTI Salud Global del CSIC

  • Gutiérrez-Díaz, Isabel
  • Molinero, Natalia
  • Tolosa-Enguís, Verónica
  • Bäuerl, Christine
  • Collado, María Carmen
  • Moreno-Arribas, M. Victoria
  • Sanz Herranz, Yolanda
  • Delgado, Susana
Financiación por la Comisión Europea – NextGeneration EU (Reglamento UE 2020/2094), a través de la Plataforma de Salud Global del CSIC (PTI Salud Global). IGD agradece la financiación por MCIN/AEI/10.13039/501100011033 y por la Unión Europea “NextGenerationEU”/PRTR (ref. FJC2021-047052-I). CB y MCC agradecen la financiación de la Fundación LaMarató-TV3 (MilkCORONA, ref. 202106) y la colaboración con el proyecto “KidsCorona Child and Mother COVID-19”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota and inflammatory mediators differentiate IgE mediated and non-IgE mediated cases of cow's milk protein at diagnosis

  • Castro Reigía, Ana María
  • Gutiérrez-Díaz, Isabel
  • Saiz, María L.
  • Navarro, Sandra
  • Suárez, Marta
  • Carbajal, Ignacio
  • García, Águeda
  • Sariego, Lydia
  • Toyos, Paula
  • Rodríguez, Silvia
  • Jiménez, Santiago
  • González, David
  • Molinos, Cristina
  • Pérez-Solis, David
  • Fernández, Porfirio
  • Suárez-Álvarez, Beatriz
  • Margolles Barros, Abelardo
  • Díaz, Juan J
  • Delgado, Susana
Objective Analyze fecal and blood samples at point of diagnosis in IgE mediated cow's milk protein allergy (CMPA) and non-IgE mediated (NIM)-CMPA patients to look for potential new biomarkers. Patients and Methods Fourteen patients with IgE mediated CMPA and 13 with NIM-CMPA were recruited in three hospitals in the north of Spain, and were compared with 25 infants from a control group of the same age range. To characterize intestinal microbiota, 16S rDNA gene and internal transcribed spacer amplicons of bifidobacteria were sequenced with Illumina technology. Fatty acids were analyzed by gas chromatography, meanwhile intestinal inflammation markers were quantified by enzyme-linked immunosorbent assay and a multiplex system. Immunological analysis of blood was performed by flow cytometry. Results The fecal results obtained in the NIM-CMPA group stand out. Among them, a significant reduction in the abundance of Bifidobacteriaceae and Bifidobacterium sequences with respect to controls was observed. Bifidobacterial species were also different, highlighting the lower abundance of Bifidobacterium breve sequences. Fecal calprotectin levels were found to be significantly elevated in relation to IgE mediated patients. Also, a higher excretion of IL-10 and a lower excretion of IL-1ra and platelet derived growth factor-BB was found in NIM-CMPA patients. Conclusions The differential fecal parameters found in NIM-CMPA patients could be useful in the diagnosis of NIM food allergy to CM proteins., This work was supported by Spanish Ministry of Science and Innovation reference: PID2019-104546RB-I00/AEI/10.13039 and Principality of Asturias Government (FICYT, supported by FEDER) Grant AYUD/2021/50910. I. G-D. has a grant FJC2021-047052-I financed by MCIN/AEI/10.13039/501100011033 and by European Union “NextGenerationEU/PRTR”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evolutive Study of Dietary Aspects and Intestinal Microbiota of Pediatric Cohort with Cow's Milk Protein Allergy

  • Castro, Ana M.
  • Navarro, Sandra
  • Carvajal, Ignacio
  • García, Agueda
  • Suárez, Marta
  • Toyos, Paula
  • Rodríguez, Silvia
  • Jimenez, Santiago
  • González, David
  • Molinos, Cristina
  • Pérez-Solís, David
  • Fernández, Porifirio
  • Margolles Barros, Abelardo
  • Díaz-Martín, Juan José
  • Gutiérrez-Díaz, Isabel
  • Delgado, Susana
One of the most common food allergies in the pediatric population is allergy to cow's milk protein (CMPA). Treatment consists of avoiding cow's milk proteins in lactating mothers and/or using therapeutic formulas based on hydrolysates or vegetable formulas. In infants with CMPA at diagnosis, a different gut microbial profile has been found compared to healthy children, with a reduction in beneficial bacteria. The aim of this study was to evaluate changes in the gut microbiota profile and its metabolites, dietary patterns and anthropometric variables in a pediatric cohort with CMPA after six months on a restrictive diet compared to healthy controls., This research was funded by the Spanish Ministry of Science and Innovation, Grant/Award Number: PID2019-104546RBI00/AEI/10.13039; and the Principality of Asturias Government, Grant/Award Number: Grant AYUD/2021/50910. I.G.-D. was awarded with MCIN/AEI/10.13039/501100011033, grant number: FJC2021-047052-I, support from European Union Next Generation EU/PRTR, and A.M.C. was awarded with a fellowship from ISPA with support from Fundació Banc Sabadell., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The intestinal microbiome of infants with cow's milk-induced FPIES is enriched in taxa and genes of enterobacteria

  • Castro Reigía, Ana María
  • Sabater, Carlos
  • Gutiérrez-Díaz, Isabel
  • Navarro, Sandra
  • Rodriguez, Silvia
  • Molinos, Cristina
  • Jiménez, Santiago
  • Claver, Angela
  • Espin, Beatriz
  • Domínguez, Gloria
  • Coronel, Cristóbal
  • Toyos, Paula
  • Sariego, Lydia
  • Fernández, Porfirio
  • Perez, David
  • Margolles Barros, Abelardo
  • Díaz-Martín, Juan José
  • Delgado, Susana
Sequencing files and metadata were deposited inthe Sequence Read Archive of the National Centerfor Biotechnology Information under bioprojectscodes PRJNA1036152 for amplicons sequences andPRJNA1037775 for shotgun sequences, Food protein-induced enterocolitis syndrome (FPIES) is a severe type of non-IgE (immunoglobulin E)-mediated (NIM) food allergy, with cow's milk (CM) being the most common offending food. The relationship between the gut microbiota and its metabolites with the inflammatory process in infants with CM FPIES is unknown, although evidence suggests a microbial dysbiosis in NIM patients. This study was performed to contribute to the knowledge of the interaction between the gut microbiota and its derived metabolites with the local immune system in feces of infants with CM FPIES at diagnosis., IsabelGutiérrez‐Díaz has a grant FJC2021‐047052‐I financed byMCIN/AEI/10.13039/501100011033. Ana M. Castro ac-knowledges her predoctoral research contract funded bythe Instituto de Investigación Sanitaria del Principado deAsturias and Fundació Banc Sabadell. The work waspartially supported by The Spanish Ministry of Science andInnovation through the project MICROALERGYMILK(PID2019‐104546RB‐I00/AEI/10.13039/) and FJC2019‐042125‐I. Susana Delgado is part of the CSIC's GlobalHealth Platform (PTI Salud Global), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Changes in intestinal microbiota in pediatric cystic fibrosis patients after 6 months of elexacaftor-tezacaftor-ivacaftor therapy

  • Gutiérrez-Díaz, Isabel
  • Gutiérrez-Martinez, Jose R.
  • García-Romero, Ruth
  • Vicente-Santamaría, Saioa
  • De La Mano-Hernández, Agustín
  • Torcuato-Rubio, Encarnación
  • Garriga-Garcia, Maria
  • Martin-Fernández, Carmen
  • Baston-Paz, Natalia
  • Simon-Bernaldo de Quiros, Clara
  • Díaz-Martín, Juan J.
  • Delgado, Susana
  • González-Jiménez, David
Cystic fibrosis (CF) is frequently associated with gastrointestinal problems, including intestinal microbiota dysbiosis. Cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies, such as elexacaftor-tezacaftor-ivacaftor (ELX/TEZ/IVA), have demonstrated improvements in lung function, abdominal symptoms, and quality of life in patients with CF. However, the impact of these modulators on the intestinal microbiota in the pediatric population remains incompletely understood. The objective of this study was to characterize the changes in the intestinal microbiota of pediatric patients with CF after 6 months of treatment with ELX/TEZ/IVA., This study was funded by “Beca de Investigación Sira Carrasco de la Sociedad Española de Gastroenterología Hepatología y Nutrición Pediátrica (SEGHNP)” Edition 2024 and “Becas de Investigación fundación Ernesto Sánchez Villares” Edition 2023. I.GD. has a grant FJC2021‐047052‐I financed by MCIN/ AEI/10.13039/501100011033 and by European Union “NextGenerationEU/PRTR.”, Peer reviewed